B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GAK

MOLECULAR TARGET

cyclin G associated kinase

UniProt: O14976NCBI Gene: 258073 compounds

GAK (cyclin G associated kinase) is targeted by 73 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GAK

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1gefitinib5.67290
2erlotinib5.55256
3imatinib5.47236
4sb 2035804.92136
5alvocidib4.5291
6tozasertib4.3375
7vandetanib4.3073
8ponatinib4.2670
9ruxolitinib4.2368
10bosutinib4.0858
11bi 25364.0154
12midostaurin3.8546
13silmitasertib3.7843
14pazopanib3.6939
15neratinib3.6638
16abemaciclib3.6638
17sb 2021903.6437
18baricitinib3.5634
19canertinib3.5333
20pelitinib3.5032
21bms 3870323.4731
22tae 6843.4330
23fedratinib3.4029
24gilteritinib3.4029
25linifanib3.3327
26saracatinib3.3327
27sgi 17763.2625
28ribociclib3.2625
29tandutinib3.2224
30sp 6001253.2224
31alectinib3.1823
32rociletinib3.1823
33dacomitinib anhydrous3.1422
34dovitinib3.0921
35jnj 77066213.0921
36at 92833.0921
37upadacitinib3.0921
38lestaurtinib3.0420
39pacritinib3.0420
40adavosertib3.0420
41pf 037583093.0019
42ruboxistaurin2.9418
43galunisertib2.9418
44momelotinib2.8917
45orantinib2.8917
46r 4062.8316
47k 252a2.8316
48cediranib2.8316
49milciclib2.7715
50pha 6657522.7114

Showing top 50 of 73 compounds. Use the BiohacksAI search to explore all GAK modulators.

About GAK as a Drug Target

GAK (cyclin G associated kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 73 compounds with documented GAK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GAK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.